Expand URGN Menu
URGN MENU

URGN Stock Summary and Trading Ideas (Urogen Pharma Ltd. - | NASDAQ:URGN)

Charts for Today's Stock Price and Implied Volatility in Urogen Pharma Ltd. -

14-Mar-2025

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for URGN by Theoretical Edge and Win Rates

Sentiment

News

UroGen Pharma to Present at Upcoming Investor Conferences

Business Wire (Thu, 30-Jan 8:00 AM ET)

Trading Statistics

Key Ratios

Urogen Pharma Ltd. - (URGN) Frequently Asked Questions

What does Urogen Pharma Ltd. - do?

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

What symbol and exchange does Urogen Pharma Ltd. - shares trade?

Urogen Pharma Ltd. - trades on the NASDAQ stock market under the symbol URGN.

What is Urogen Pharma Ltd. - stock price doing today?

As of March 14, 2025, URGN stock price climbed to $11.07 with 258,521 million shares trading.

How much is Urogen Pharma Ltd. - worth?

URGN has a market cap of $510.26 million. This is considered a Small Cap stock.

How much money does Urogen Pharma Ltd. - make?

Last quarter Urogen Pharma Ltd. - reported $25 million in Revenue and -$.80 earnings per share. This fell short of revenue expectation by $-685,000 and missed earnings estimates by -$.08.

What is the highest and lowest price Urogen Pharma Ltd. - traded in the last 3 year period?

In the last 3 years, URGN traded as high as $24.13 and as low as $4.85.

What are the top ETFs holding Urogen Pharma Ltd. -?

The top ETF exchange traded funds that URGN belongs to (by Net Assets): IWM, IWO, IBB, IZRL, VTWO.

Is Urogen Pharma Ltd. - (URGN) a good investment?

URGN has underperformed the market in the last year with a return of -22.7%, while SPY returned +11.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in URGN shares. However, URGN has outperformed the market in the last 3 month and 2 week periods, returning -2.5% and +17.0%, while SPY returned -6.5% and -5.3%, respectively. This indicates URGN has been having a stronger performance recently.

What are the support and resistance levels for Urogen Pharma Ltd. - (URGN)?

URGN support price is $10.41 and resistance is $11.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that URGN shares will trade within this expected range on the day.